Executive functioning, illness course, and relapse/recurrence in continuation and maintenance treatment of late-life depression: is there a relationship?

The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
Meryl A ButtersCharles F Reynolds

Abstract

The authors tested the hypothesis that impaired executive functioning leads to high rates of relapse and recurrence in late-life depression. They analyzed data from subjects participating in two independent intervention trials. Study I included 53 elderly depressed patients who participated in an open trial comparing the efficacy of paroxetine and nortriptyline and recurrence prevention over 18 months. Study II focused on 146 elderly depressed patients who received open treatment with paroxetine in a relapse-prevention study over 4 months of continuation treatment. They examined the effect of cognitive functioning, in general, and executive functioning, in particular, on time-to-relapse/recurrence, using baseline and post-treatment measures of neuropsychological functioning. The associations between cognitive measures and both probability of, and time-to-relapse/recurrence were small and statistically nonsignificant. Data failed to support the hypothesis that cognitive impairment, in general, or executive dysfunction, in particular, predicts relapse or recurrence of major depression in late life. Authors recommend future testing of the hypothesis with detailed, comprehensive measures over longer periods of observation during ma...Continue Reading

Citations

Feb 27, 2013·Molecular Psychiatry·W D TaylorG S Alexopoulos
Aug 25, 2007·Annual Review of Clinical Psychology·Philip D HarveyChristopher R Bowie
Jun 26, 2007·Psychological Medicine·D C Steffens, G G Potter
Nov 16, 2013·The Psychiatric Clinics of North America·Sarah Shizuko Morimoto, George S Alexopoulos
Feb 8, 2008·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Jordan F KarpDebra K Weiner
Mar 2, 2011·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Helen LavretskyMichael R Irwin
Jun 29, 2011·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Joost B SandersAartjan T F Beekman
Aug 19, 2015·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Monique A PimontelJoel R Sneed
Sep 3, 2010·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Sarah Shizuko MorimotoGeorge S Alexopoulos
Aug 1, 2015·International Journal of Geriatric Psychiatry·Madeleine S GoodkindRuth M O'Hara
Sep 27, 2008·International Journal of Geriatric Psychiatry·Virginia Elderkin-ThompsonAnand Kumar
Mar 4, 2008·International Journal of Geriatric Psychiatry·Corinne FischerSean B Rourke
Feb 15, 2007·International Journal of Geriatric Psychiatry·Hillary R BognerUNKNOWN PROSPECT Group
Jan 10, 2012·International Journal of Geriatric Psychiatry·R ParanthamanR C Baldwin
Mar 1, 2006·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Wayne J KatonJürgen Unützer
Jul 16, 2005·Biological Psychiatry·George S AlexopoulosFaith Gunning-Dixon
Oct 21, 2015·Frontiers in Psychiatry·Jeffrey N MotterJoel R Sneed
Nov 6, 2012·Psychiatry Research·Christopher G BeeversW Todd Maddox
Jul 22, 2014·Cortex; a Journal Devoted to the Study of the Nervous System and Behavior·W Todd MaddoxChristopher G Beevers
Apr 28, 2007·The Australian and New Zealand Journal of Psychiatry·Richard J PorterPeter Gallagher
May 25, 2005·Journal of Geriatric Psychiatry and Neurology·Jan Mohlman
Dec 17, 2009·The Australian and New Zealand Journal of Psychiatry·Katie M Douglas, Richard J Porter
Mar 1, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Gwenn S SmithJovier D Evans
Oct 21, 2017·Aging & Mental Health·Juan Carlos MélendezTeresa Mayordomo
May 15, 2007·The Neurologist·Guy G Potter, David C Steffens
Aug 20, 2009·Bipolar Disorders·Felicity NgUNKNOWN International Society for Bipolar Disorders
Dec 31, 2010·International Journal of Geriatric Psychiatry·Michelle E Culang-ReinliebJoel R Sneed
Nov 20, 2009·Journal of Psychosocial Nursing and Mental Health Services·Robert H Howland

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.